The experiments described in Figures 1–4 provide ample evidence to support the hypothesis that low concentrations of endogenous EGFR ligands accessible to cells in tumor xenografts explain our observation of a small pool of detectable intracellular EGFR-GFP vesicles. This evidence concerns the gene EGFR and neoplasm.